Results 271 to 280 of about 32,738 (290)

Intraoperative fluid restriction in hyperthermic intraperitoneal chemotherapy

Journal of Surgical Research, 2018
Multiple studies highlight the importance of liberal fluid administration in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Over-resuscitation can delay recovery and wound healing. We report an intraoperative protocol that restricts fluid administration and minimizes morbidity.Retrospective analysis of 35 patients ...
Tariq Almerey, Emmanuel M. Gabriel, Klaus D. Torp, Sanjay P. Bagaria   +3 more
openaire   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Techniques

2015
Peritoneal carcinomatosis has long been considered a terminal condition and constitutes a difficult therapeutic challenge given the dismal prognosis associated with this entity and the debilitating effect it exerts on affected patients. Over the past decade, novel therapeutic approaches to peritoneal surface malignancies have emerged.
Salvatore Virzì, Domenico Rosario Iusco, Serena Bonomi, Antonio Grassi   +3 more
openaire   +1 more source

Cytoreduction and hyperthermic intraperitoneal chemotherapy: The learning curve reassessed

European Journal of Surgical Oncology (EJSO), 2016
CytoReductive Surgery and Hyperthermic IntraPEritoneal Chemotherapy (CRS-HIPEC) is now the preferred treatment of many peritoneal surface malignancies. In this retrospective study we aimed to analyze how several performance indicators changed during the first 100 CRS-HIPEC procedures in hospitals which recently introduced this treatment, and compare ...
Kuijpers, A. M., Hauptmann, M., Aalbers, A. G., Nienhuijs, S. W., de Hingh, I. H., Wiezer, M. J., van Ramshorst, B., van Ginkel, R. J., Havenga, K., Verwaal, V. J.   +9 more
openaire   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy: An Overview #412

Journal of Palliative Medicine, 2021
Ryan, Morgan, Sandy, Tun, Oliver S, Eng
openaire   +2 more sources

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

BJA Education, 2021
S, Durnford, L, Boss, J, Bell
openaire   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined with Surgery: A 12-Year Meta-Analysis of this Promising Treatment Strategy for Advanced Gastric Cancer at Different Stages

Annals of Surgical Oncology, 2022
Jian-Feng Zhang, Ling Lv, Shuai Zhao, Qian Zhou, Cheng-gang Jiang   +4 more
semanticscholar   +1 more source

Selection of Chemotherapy in Hyperthermic Intraperitoneal Chemotherapy

2017
The peritoneum consists of a layer of mesothelial cells covering all abdominal organs and the abdominopelvic wall. Peritoneal metastases are formed after exfoliation of free tumor cells from a primary tumor invading the peritoneum. Consequently, most peritoneal metastases originate from abdominal organs such as the colon, rectum, stomach, or ovaria ...
H. J. Braam, F. J. H. Hoogwater
openaire   +1 more source

Hyperthermic Intraperitoneal Chemotherapy

Surgical Oncology Clinics of North America, 2012
Santiago González-Moreno, Luis González-Bayón, Gloria Ortega-Pérez   +2 more
openaire   +1 more source

Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

Journal of Clinical Oncology, 2003
V. Verwaal, S. van Ruth, E. de Bree, Gooike W van Sloothen, H. van Tinteren, H. Boot, F. Zoetmulder   +6 more
semanticscholar   +1 more source

Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix

Annals of Surgical Oncology, 2022
F. Lopez-Ramirez, V. Gushchin, M. Sittig, M. King, E. Baron, A. Nikiforchin, C. Nieroda, A. Sardi   +7 more
semanticscholar   +1 more source